About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
To download the full report, click here.
A better understanding of the players involved in the pharmaceutical supply chain, and the role each plays in determining what patients ultimately pay for their prescriptions, can help consumers and policymakers find answers to their questions and concerns about affordability and access to medicines. Drawing from published materials and interviews with industry experts, this paper explains the financial flows that occur as brand medicines move through the supply chain for retail, mail-order, and specialty drugs. Illustrative examples are provided for 3 patients: Janet, Scott, and Diane. Because payment terms are determined through confidential negotiations between stakeholders, the terms of individual contracts are highly variable and may differ from these hypothetical examples.
follow the dollar executive summary preview
Report
Follow the Dollar Executive Summary
follow the dollar executive summary preview